Efficacy and Acceptability of Glycemic Control of Glucagon-Like Peptide-1 Receptor Agonists among Type 2 Diabetes: A Systematic Review and Network Meta-Analysis

• Zhixia Li,

  Affiliation Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China

  ⨯
• Yuan Zhang,

  Affiliation Department of Clinical Epidemiology and Biostatistics, McMaster University, 1280 Main Street West, Hamilton, ON, Canada

  ⨯
• Xiaochi Quan,

  Affiliation Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China

  ⨯
• Zhirong Yang,

  Affiliation Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China

  ⨯
• Xiantao Zeng,

  Affiliation Center for Evidence-based and Translational Medicine, Zhongnan Hospital, Wuhan University, Wuhan, China

  ⨯
• Linong Ji,

  Affiliation Department of Endocrinology and Metabolism, People’s Hospital, Peking University, Beijing, China

  ⨯
• Feng Sun ,

  Contributed equally to this work with: Feng Sun, Siyan Zhan

  * E-mail: siyan-zhan@bjmu.edu.cn (SZ); sunfeng@bjmu.edu.cn (FS)

  Affiliation Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China

  ⨯
• Siyan Zhan

  Contributed equally to this work with: Feng Sun, Siyan Zhan

  * E-mail: siyan-zhan@bjmu.edu.cn (SZ); sunfeng@bjmu.edu.cn (FS)

  Affiliation Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China

  ⨯